Wuhan Institute of Sports, No. 461 Luoyu Road, Hongshan District, Wuhan, Hubei Province, China.
BMC Musculoskelet Disord. 2023 Aug 31;24(1):698. doi: 10.1186/s12891-023-06701-6.
Patellofemoral pain syndrome is a prevalent sports injury that affects athletes both in their daily lives and during training. This condition causes pain in the area where the kneecap and thigh bone meet, and it can be quite debilitating. Whether an athlete is simply going about their day or pushing themselves to the limit during a workout, patellofemoral pain can be a significant hindrance.
The purpose of this study is to investigate the impact of combining Instrument-Assisted Soft Tissue Mobilization (IASTM) treatment with blood flow restriction training on individuals with patellofemoral pain. Specifically, the study will assess improvements in pain levels, functional ability, strength, and joint mobility resulting from this treatment approach.
Twenty-six patients diagnosed with patellofemoral pain were selected as observation subjects and randomly divided into two groups: the IASTM combined with blood flow restriction training treatment group (n = 13) and the IASTM treatment group alone (n = 13). The treatment period was 4 weeks. In this study, we conducted a comparison and analysis of the knee's visual analogue pain scale (VAS), Lysholm score, and a modified version of the Thomas test (MTT) at three different time points.In this subject paper, we compared and analyzed the VAS score of the knee, Lysholm score of the knee, and MTT at three different time points-before treatment, immediately after the first treatment, and after four weeks of treatment. Additionally, we recorded data using a maximum isometric muscle strength testing system for the lower extremity extensors four weeks before and after treatment.
In comparing the Lysholm scores within the groups, a significant difference was observed between the two groups following the initial treatment and after 4 weeks of treatment (p < 0.05). The scores increased, indicating a significant improvement in function. The VAS scores significantly differed after the first treatment and 4 weeks of treatment compared to before treatment (p < 0.05), indicating a significant improvement in pain. Additionally, after 4 weeks of treatment, the strength of the extensor muscle in the lower extremity significantly improved (p < 0.001). However, there was no significant difference in the strength test between the groups (p > 0.05). The MTT test revealed significant changes in the three joint angles before and after treatment (p > 0.05), suggesting an improvement in joint mobility. Overall, these results demonstrate the effectiveness of the treatment in improving pain and muscle strength in the lower extremity.
The combination of IASTM treatment and blood flow restriction has been shown to significantly reduce pain and improve periprosthetic soft tissue flexibility. Additionally, IASTM treatment alone was found to be more effective in improving knee pain and muscle flexibility, ultimately leading to increased knee strength in a pain-free state. In terms of the overall treatment outcome, it was found that the combined treatment was significantly more effective than the adjuvant soft tissue release treatment alone.
髌股疼痛综合征是一种常见的运动损伤,影响运动员的日常生活和训练。这种情况会导致膝盖骨和大腿骨连接处疼痛,而且可能非常虚弱。无论运动员是在日常生活中还是在锻炼时达到极限,髌股疼痛都可能是一个重大障碍。
本研究旨在探讨结合使用仪器辅助软组织松解(IASTM)治疗和血流限制训练对髌股疼痛患者的影响。具体来说,本研究将评估这种治疗方法对疼痛水平、功能能力、力量和关节活动度的改善。
选择 26 名被诊断为髌股疼痛的患者作为观察对象,并随机分为两组:IASTM 联合血流限制训练治疗组(n=13)和 IASTM 治疗组(n=13)。治疗期为 4 周。在这项研究中,我们在三个不同的时间点(治疗前、第一次治疗后和治疗后 4 周)对膝关节的视觉模拟疼痛量表(VAS)、Lysholm 评分和改良 Thomas 试验(MTT)进行了比较和分析。在本研究中,我们比较和分析了治疗前、第一次治疗后和治疗后 4 周的膝关节 VAS 评分、膝关节 Lysholm 评分和 MTT。此外,我们还在治疗前后四周使用下肢伸肌最大等长肌肉力量测试系统记录了数据。
在组内比较 Lysholm 评分时,两组在初始治疗后和 4 周治疗后均有显著差异(p<0.05)。分数增加,表明功能显著改善。与治疗前相比,VAS 评分在第一次治疗后和 4 周治疗后均有显著差异(p<0.05),表明疼痛明显改善。此外,治疗后 4 周,下肢伸肌的力量明显提高(p<0.001)。然而,两组之间的力量测试没有显著差异(p>0.05)。MTT 试验显示治疗前后三个关节角度有显著变化(p>0.05),提示关节活动度改善。总的来说,这些结果表明,IASTM 治疗联合血流限制治疗可显著减轻疼痛,改善假体周围软组织的柔韧性。此外,单独使用 IASTM 治疗在改善膝关节疼痛和肌肉柔韧性方面更为有效,最终导致膝关节在无痛状态下的力量增加。就整体治疗效果而言,联合治疗明显优于单独的辅助软组织松解治疗。